Clerkenwell Therapist Training Programme

The Certificate in Psychedelic-Assisted Therapies and Research is a comprehensive program designed to provide students with a thorough understanding of the therapeutic potential of psychedelics and make them eligible to participate in clinical trials as therapists. The course covers a wide range of topics, including the history of psychedelic use in medicine, current research on the safety and efficacy of psychedelics in treating mental health conditions, and the ethical and legal considerations surrounding their use.

Throughout the program, students will learn from leading experts in the field, including researchers, clinicians, and policymakers. The course will also include hands-on training in the administration and facilitation of psychedelic-assisted therapies, as well as the design and implementation of research studies.

Upon completion of the program, students will have the knowledge and skills necessary to safely and effectively integrate psychedelic-assisted therapies into their professional practice and contribute to the ongoing research in this field.

This course is intended for healthcare professionals, researchers, and individuals who are interested in learning about the use of psychedelics in therapy and research. It’s a part-time course which can be completed in 12 months.

The next cohort hasn’t been announced, but will probably take place later in 2023.

Find More Info on Clerkenwell Therapist Training Programme on PsychedelicsCourses.com

Related Company

Clerkenwell Health
Clerkenwell is a clinical research organisation (CRO) in the UK that supports drug developers as they attempt to commercialise psychedelic therapies. Clerkenwell offers support from preclinical studies up to Phase III of the drug development process.